Literature DB >> 8609841

Menstrual history as a determinant of current bone density in young hirsute women.

C Castelo-Branco1, F Pons, M J Martinez de Osaba, J Garrido, A Fortuny.   

Abstract

There is evidence that bone mass is influenced by estrogen, declining in situations characterized by a decrease in the production of this hormone. Usually, amenorrhea and oligomenorrhea are associated with a state of hypoestrogenism, and both situations are frequent in hirsute patients. The aim of the present study was to analyze the relationship between bone mass and menstrual cyclicity in hirsute women. A total of 52 nulliparous women complaining of hirsutism in various degrees with associated oligomenorrhea/amenorrhea (OA) in 27 cases and eumenorrhea in 25 were included in this study. Basal serum levels of follicle-stimulating hormone (FSH), luteinzing hormone (LH), estradiol-17beta (E2), prolactin (PRL), testosterone (T), androstenedione (A4) dehydroepiandrosterone sulfate (DHEAS), 17-hydroxyprogesterone (OHP), and SHBG were determined, and the area under the curve (AUC) for E2 was plotted. Bone mineral density (BMD) was assessed by dual-energy x-ray absorptiometry (DEXA). The mean age for eumenorrheic patients was 26 years (range, 17 to 31), and for OA patients, 24 (range, 16 to 29). Both groups had similar Ferriman-Gallwey scores. Basal levels of PRL, LH, FSH, E2, T, A4, OHP, and DHEAS were similar for eumenorrheic and OA patients. The AUC for E2 was significantly higher for eumenorrheic patients, and DEXA at the lumbar spine demonstrated a significant difference between eumenorrheic (1.222 +/- 0.240 g/cm2) and OA (1.016 +/- 0.108 g/cm2) hirsute women (P < .01). In conclusion, OA, due to a relative hypoestrogenism, may be correlated with osteopenia in young hirsute women.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609841     DOI: 10.1016/s0026-0495(96)90229-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  Prepubertal girls with premature adrenarche have greater bone mineral content and density than controls.

Authors:  A B Sopher; J C Thornton; M E Silfen; A Manibo; S E Oberfield; J Wang; R N Pierson; L S Levine; M Horlick
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

2.  Obesity and Insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women.

Authors:  Camila F Pereira-Eshraghi; Codruta Chiuzan; Yuan Zhang; Rachel H Tao; Matthew McCann; Y Dana Neugut; Alison Printz; Ilene Fennoy; Melanie Cree-Green; Sharon E Oberfield; Aviva B Sopher
Journal:  Horm Res Paediatr       Date:  2020-04-29       Impact factor: 2.852

Review 3.  Bone management in hematologic stem cell transplant recipients.

Authors:  D L Kendler; J J Body; M L Brandi; R Broady; J Cannata-Andia; M J Cannata-Ortiz; A El Maghraoui; G Guglielmi; P Hadji; D D Pierroz; T J de Villiers; R Rizzoli; P R Ebeling
Journal:  Osteoporos Int       Date:  2018-09-03       Impact factor: 4.507

4.  Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome.

Authors:  D Glintborg; A P Hermann; L M Rasmussen; M Andersen
Journal:  J Endocrinol Invest       Date:  2012-11-26       Impact factor: 4.256

5.  Steroidal contraceptive use is associated with lower bone mineral density in polycystic ovary syndrome.

Authors:  Lisa J Moran; R L Thomson; J D Buckley; M Noakes; P M Clifton; R J Norman; G D Brinkworth
Journal:  Endocrine       Date:  2015-05-10       Impact factor: 3.633

Review 6.  Osteoporosis management in hematologic stem cell transplant recipients: Executive summary.

Authors:  D L Kendler; J J Body; M L Brandi; R Broady; J Cannata-Andia; M J Cannata-Ortiz; A El Maghraoui; G Guglielmi; P Hadji; D D Pierroz; T J de Villiers; P R Ebeling; R Rizzoli
Journal:  J Bone Oncol       Date:  2021-04-23       Impact factor: 4.072

Review 7.  The impact of sex steroids on osteonecrosis of the jaw.

Authors:  Ranhee Kim; Sung Woo Kim; Hoon Kim; Seung-Yup Ku
Journal:  Osteoporos Sarcopenia       Date:  2022-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.